Annual Drug Patent Expirations for XYWAV
Xywav is a drug marketed by Jazz and is included in one NDA. It is available from one supplier. There are thirteen patents protecting this drug.
Drug patent litigation for XYWAV.
This drug has thirty-four patent family members in twenty-five countries.
The generic ingredient in XYWAV is calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate. One supplier is listed for this compound. Additional details are available on the calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
You must log in to post a comment.